Prevalence of Osteoporosis Among Inflammatory Bowel Disease Patients in Assiut University Hospitals
1 other identifier
observational
55
0 countries
N/A
Brief Summary
the prevalence of osteoporosis in patients with inflammatory bowel disease in Assiut University Hospitals.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Jan 2025
Shorter than P25 for all trials
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 13, 2024
CompletedFirst Posted
Study publicly available on registry
September 19, 2024
CompletedStudy Start
First participant enrolled
January 1, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
January 1, 2026
CompletedSeptember 19, 2024
September 1, 2024
1 year
September 13, 2024
September 16, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
1- To detect the prevalence of osteoporosis in patients with inflammatory bowel disease in Assiut University Hospitals.
1 year
Interventions
Bone density scans
Eligibility Criteria
cases of IBD in Internal medicine department, Assiut University Hospitals.
You may qualify if:
- The study will include Patients aged 18-65 years, diagnosed with either Crohn's disease or ulcerative colitis, The diagnosis of UC and CD based on the clinical, endoscopic, laboratory and histological criteria according to ECCO Guidelines. The activity of IBD will be determined with the use of the Crohn\'s Disease Activity Index (CDAI) for CD, and the Mayo score for UC, data collection will obtained over one year duration
You may not qualify if:
- Patients Known to have osteoporosis and on treatment
- Female patients on COCs
- Patients with malignancy
- Patients with CKD
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Dina Fathylead
Related Publications (2)
Lewandowski K, Kaniewska M, Wiecek M, Szwarc P, Panufnik P, Tulewicz-Marti E, Walicka M, Franek E, Rydzewska G. Risk Factors for Osteoporosis among Patients with Inflammatory Bowel Disease-Do We Already Know Everything? Nutrients. 2023 Feb 24;15(5):1151. doi: 10.3390/nu15051151.
PMID: 36904150RESULTFrisoli A Jr, Paes AT, Kimura AD, Azevedo E, Ambrosio V. Measuring forearm bone density instead of lumbar spine bone density improves the sensitivity of diagnosing osteoporosis in older adults with cardiovascular diseases: Data from SARCOS study. Bone Rep. 2021 Oct 4;15:101134. doi: 10.1016/j.bonr.2021.101134. eCollection 2021 Dec.
PMID: 34660851RESULT
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- OTHER
- Time Perspective
- CROSS SECTIONAL
- Target Duration
- 1 Year
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Dina Fathy
Study Record Dates
First Submitted
September 13, 2024
First Posted
September 19, 2024
Study Start
January 1, 2025
Primary Completion
January 1, 2026
Study Completion
January 1, 2026
Last Updated
September 19, 2024
Record last verified: 2024-09